Photo provided by Avulux. Access has been expanded to Avulux lenses. ABB Optical Group customers now can offer patients Avulux lenses through its ABB Labs.
Access expanded to Avulux migraine and light sensitivity lenses
Sept. 10, 2025
ABB Optical Group announced that ABB Labs has added Avulux Migraine and Light Sensitivity lenses to its portfolio of lens designs.
Avulux describes its lenses as “the only clinically proven lens that precisely filters light to help people living with migraine and light sensitivity.”
“ABB is committed to offering our eye care provider customers the highest quality and most innovative lenses,” said James Gilchrist, president of ABB Optical Group. “We continue to expand our offerings so ECPs can differentiate their practice and provide their patients the widest range of solutions from a single trusted source. For individuals struggling with light sensitivity and migraine, we’re excited about the difference this can make for patients.”
Precision Filtering Lens Technology
Avulux lenses use a multi-band precision optical filter that works by filtering up to 97% of harmful blue, amber and red light while letting in soothing green light. Avulux is the only lens clinically proven to help people living with migraine and light sensitivity. In a 2020 double-blind, randomized placebo-controlled study conducted by an independent clinical research organization, the Avulux lens achieved both clinical and statistical significance compared to a clear placebo lens. For more information about Avulux, visit ecp.avulux.com.
Partnership to Expand Access
“We are thrilled to welcome ABB Labs into our growing network of labs as a center of excellence. Together, we can bring Avulux lenses to more people living with migraine and light sensitivity,” said Dr. Charles Posternack, president and CEO of Avulux. “ABB’s reputation for quality and service makes them an ideal partner as we expand access to our innovative light management solution.”
Industry-Leading Service and Satisfaction
ABB Labs have the industry’s best service and quality of any national lab network, according to the results from a recent independent study.* ABB Labs customers had a satisfaction rating of 92% with over 98% of lab orders meeting customer quality expectations. More customers planned to continue doing business with ABB than with any other lab; nine out of 10 customers said they would remain ABB Labs customers in the next 12 months.
Collaboration Aims to Improve Patient Outcomes
Posternack and Gilchrist both shared their excitement about bringing together Avulux’s product technology and ABB’s lab service to benefit ECPs. “Together we can help many more patients experience the life-changing benefits of better vision and migraine-free days.”
For information on how to begin offering Avulux through ABB, visit ecp.avulux.com/abb.
*Data Source: According to an independent study of 307 eyecare professionals conducted by Emergent Research. Data on file.
